News and Events

Nov 20, 2019

Researchers used artificial intelligence (AI) to evaluate stem cell-derived “patches” of retinal pigment epithelium (RPE) tissue for implanting into the eyes of patients with age-related macular degeneration (AMD), a leading cause of blindness.

Nov 19, 2019

National Institutes of Health researchers, along with researchers at Siemens, have developed a high-performance, low magnetic-field MRI system that vastly improves image quality of the lungs and other internal structures of the human body. The new system is more compatible with interventional devices that could greatly enhance image-guided procedures that diagnose and treat disease, and the system makes medical imaging more affordable and accessible for patients.

Nov 4, 2019

Researchers at the National Institutes of Health and their colleagues at Massachusetts General Hospital (MGH) in Boston report that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV. The study was conducted by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Cancer Institute, both parts of NIH. The findings were published online today in The Lancet HIV.

Nov 4, 2019

Investigators at the National Institutes of Health have found that sesame allergy is common among children with other food allergies, occurring in an estimated 17% of this population. In addition, the scientists have found that sesame antibody testing — whose utility has been controversial — accurately predicts whether a child with food allergy is allergic to sesame. The research was published on Oct. 28 in the journal Pediatric Allergy and Immunology.

Sep 9, 2019

In 2016, the National Cancer Institute (NCI) had initiated the Cancer Moonshot to accelerate cancer preventive, diagnostic and therapeutic innovations and medical products development; encourage collaborations and improve data sharing in the vast and dynamic field of cancer research. Cancer Moonshot was named in the memory of President John F. Kennedy’s inspirational speech in 1962 to win a space race against the Soviet Union to land the first man on the moon.

Aug 20, 2019

The National Cancer Institute (NCI) is building a national resource of cancer cell models derived from patients in NCI-sponsored clinical trials. This Patient-Derived Models Repository (PDMR) will contain patient-derived xenografts, primary and metastatic tumor cell cultures, blood specimens, cancer associated fibroblasts and organoids to boost public-private partnerships and academic drug discovery efforts.  The tissue samples from SCLC, pancreatic, bladder, head and neck, sarcoma, Non-Hodgkin Lymphoma and melanoma will also be stored and made publically available upon request.

Aug 14, 2019

more than 2 million people worldwide, multiple sclerosis is a disease for which there is no cure. The disease starts when the immune system attacks myelin, a protective coating that forms around nerve cells in a person’s brain and spinal cord, to produce a variety of initial symptoms, including blurred or double vision, problems with muscle strength, balance and coordination, and abnormal sensations. 

Jul 29, 2019

The mission of NIMH is to translate the understanding and treatment of mental illnesses through basic and clinical research leading to prevention, recovery and cure. Many pharmaceutical companies generally prefer to invest in more profitable disease areas. NIMH Intramural Research Program (IRP) initiated Translational Neuropsychopharmacology Task Force (TNTF) with expert scientists from the pharmaceutical industry and the NIH to recommend new project proposals for grant support by the NIMH IRP.

Jul 26, 2019

Over 300 million people worldwide are suffering from chronic depression. It is also one of the leading causes of disability in US and can be fatal as suicide kills more than 45,000 Americans annually. NIMH psychiatrist Dr. Carlos Zarate and collaborators discovered that a single intravenous dose of the “club drug” ketamine could produce significant antidepressant effects in 71% of the test subjects and remission in 29% patients with treatment-resistant depression (TRD) as compared with placebo.

Jul 1, 2019

Dr. Wiliam J. Pavan and his team at National Human Genome Research Institute (NHGRI) have established a novel diagnostic tool to predict time of onset for the rare neurodegenerative Niemann-Pick disease type C (NPC). The npc1 gene mutation leads to the lysosomal lipid storage disorder in neuronal tissue. Flowcytometric analysis of stained lysosomal structures in patient derived fibroblasts predicts the time of onset of the disease symptoms.